Volagidemab
Volagidemab Uses, Dosage, Side Effects, Food Interaction and all others data.
Volagidemab is under investigation in clinical trial NCT03117998 (Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus).
| Trade Name | Volagidemab |
| Generic | Volagidemab |
| Volagidemab Other Names | Volagidemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Volagidemab
